Divi's Laboratories Ltd.

View in App
3752.95 +22.90 ▲0.6%

26 September 2023, 04:01:00 PM
Volume: 8,442

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.divislabs.com
Market Cap 99,629.03 Cr.
Enterprise Value(EV) 95,415.94 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 55.65 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 67.44 Trailing Twelve Months Ending 2023-06
Industry PE 37.33 Trailing Twelve Months Ending 2023-06
Book Value / Share 494.34 Trailing Twelve Months Ending 2023-06
Price to Book Value 7.59 Calculated using Price: 3,752.95
Dividend Yield 0.80 Period Ending 2023-03
No. of Shares Subscribed 26.55 Cr. 265,468,580 Shares
FaceValue 2
About Divi's Laboratories Ltd.
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Divi's Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Divi's Laboratories Ltd. Performance

View details >>
1 Day
+0.61%
1 Week
-0.82%
1 Month
+3.28%
3 Month
+8.36%
6 Month
+33.74%
1 Year
+3.05%
2 Year
-26.44%
5 Year
+170.36%
10 Year
+666.64%

Divi's Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 26.37 28.91 21.98 15.55 21.00 19.30 23.90 28.16 14.89
Return on Capital Employed (%) 33.06 35.57 28.75 21.68 28.50 25.36 32.07 35.06 19.36
Return on Assets (%) 18.21 22.49 17.21 11.12 15.78 15.11 19.07 22.77 12.37

Divi's Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 2,963 3,495 4,293 5,357 5,925 6,957 7,310 9,295 11,728 12,767
Non Curr. Liab. 650 842 85 1,412 1,769 991 295 364 437 556
Curr. Liab. 627 776 520 659 653 847 1,821 1,728 2,454 1,533
Minority Int.
Equity & Liab. 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 14,857
Non Curr. Assets 1,984 2,340 1,871 3,418 3,812 4,145 3,851 4,596 5,009 5,113
Curr. Assets 2,256 2,772 3,027 4,011 4,535 4,650 5,574 6,791 9,610 9,744
Misc. Exp. not W/O
Total Assets 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 14,857

Divi's Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 3,115 3,776 4,064 3,891 4,946 5,394 6,969 8,960 7,768 7,291
Other Income 45 97 75 113 156 190 63 116 345 341
Total Income 3,160 3,874 4,139 4,005 5,102 5,584 7,032 9,076 8,112 7,632
Total Expenditure -1,949 -2,358 -2,617 -2,629 -3,073 -3,571 -4,108 -5,079 -5,398 -5,270
PBIDT 1,211 1,516 1,522 1,376 2,029 2,013 2,924 3,997 2,714 2,362
Interest -3 -5 -3 -2 -5 -7 -2 -2 -2 -1
Depreciation -136 -118 -123 -142 -169 -186 -256 -312 -343 -353
Taxation -221 -267 -335 -354 -502 -443 -682 -723 -545 -532
Exceptional Items
PAT 852 1,126 1,060 877 1,353 1,377 1,984 2,960 1,823 1,477
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 852 1,126 1,060 877 1,353 1,377 1,984 2,960 1,823 1,477
Adjusted EPS 32 42 40 33 51 52 75 112 69 56

Divi's Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 557 826 1,038 1,150 776 954 1,216 1,947 1,912 2,460
Cash Fr. Inv. -305 -521 -406 -1,140 -478 -685 -83 75 -2,195 -2,708
Cash Fr. Finan. -249 -303 -631 2 -314 -246 -1,091 -35 -532 -797
Net Change 3 3 0 13 -17 23 41 1,987 -816 -1,045
Cash & Cash Eqvt 15 18 18 -4 -21 2 43 2,030 1,215 170

Divi's Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 51.95 51.95 51.95 51.94 51.94 51.94 51.94 51.94 51.93
Public 48.05 48.05 48.05 48.06 48.06 48.06 48.06 48.06 48.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Divi's Laboratories Ltd. Announcements

View details >>
Tue, 26 Sep 2023
Press Release - USFDA Delegation Visits The Company'S Unit I At Choutuppal Telangana India
As per enclsoed press release.
Tue, 26 Sep 2023
Press Release - USFDA Delegation Visits The Company'S Unit I At Choutuppal Telangana India
As per enclsoed press release.
Tue, 26 Sep 2023
Press Release - USFDA Delegation Visits The Company'S Unit I At Choutuppal Telangana India
As per enclsoed Press Release.

Divi's Laboratories Ltd. Technical Scans

View details >>
Tue, 26 Sep 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 6 Months High Increase in 6 Months
High Increase in 5 Years High Increase in 5 Years

Divi's Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,865.20 1,124.75 +0.1%
Cipla Ltd. 93,955.61 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. 91,199.58 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. 72,659.42 5,051.00 -0.9%
Mankind Pharma Ltd. 70,114.99 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. 61,876.29 1,831.00 -0.9%
Zydus Lifesciences Ltd. 60,514.62 598.45 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.99 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-06 30.20 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.31 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.63 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 54.64 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.18 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-06 23.95 598.45 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-06 3.86 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.72 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.58 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 5.72 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.42 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-06 3.25 598.45 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 598.45 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 598.45 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 598.45 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 598.45 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.75 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,831.00 -0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 598.45 -0.6%

Divi's Laboratories Ltd. FAQ's

What is Divi's Lab share price?
Can I buy Divi's Lab shares now?
What is the Dividend Yield of Divi's Lab?
What is the Market Cap of Divi's Lab?
What are the key metrics to analyse Divi's Lab?
What is the 52 Week High and Low of Divi's Lab?
What is the trend of Divi's Lab share price?